|
FER expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.43390002491384E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.75308722672708E-12 |
| Normal-vs-Stage2 |
3.5992999691814E-09 |
| Normal-vs-Stage3 |
7.63200003195408E-09 |
| Normal-vs-Stage4 |
6.01590000037788E-07 |
| Stage1-vs-Stage2 |
1.944970E-01 |
| Stage1-vs-Stage3 |
5.326600E-01 |
| Stage1-vs-Stage4 |
8.241000E-01 |
| Stage2-vs-Stage3 |
3.963000E-01 |
| Stage2-vs-Stage4 |
3.775800E-01 |
| Stage3-vs-Stage4 |
8.202000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.1368999963679E-08 |
| Normal-vs-AfricanAmerican |
1.210370E-02 |
| Normal-vs-Asian |
6.17690000259685E-08 |
| Caucasian-vs-AfricanAmerican |
2.118200E-01 |
| Caucasian-vs-Asian |
3.977600E-01 |
| AfricanAmerican-vs-Asian |
1.166970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.847299476893E-10 |
| Normal-vs-Female |
3.96271904179457E-12 |
| Male-vs-Female |
1.179590E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.70839994875871E-09 |
| Normal-vs-Age(41-60Yrs) |
5.80140002703899E-09 |
| Normal-vs-Age(61-80Yrs) |
5.94630011896413E-10 |
| Normal-vs-Age(81-100Yrs) |
5.641200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.592800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.423900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.222200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.576800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.806800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.824600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.059400E-03 |
| Classical-VS-Follicular |
2.81950000013964E-07 |
| Classical-VS-Other |
2.736600E-01 |
| Classical-VS-Normal |
4.5850999996766E-07 |
| Tall-VS-Follicular |
1.135830E-01 |
| Tall-VS-Other |
7.953800E-01 |
| Tall-VS-Normal |
7.48289985530448E-10 |
| Follicular-VS-Other |
6.328400E-01 |
| Follicular-VS-Normal |
5.59008395129013E-12 |
| Other-VS-Normal |
3.281000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.03470010337503E-10 |
| Normal-vs-N1 |
1.92283000000071E-05 |
| N0-vs-N1 |
1.433050E-01 |
|
|
